Addictive drugs modulate GIRK-channel signaling by regulating RGS proteins

Trends in Pharmacological Sciences

Volumn 29, Issue 11, 2008, Pages 544-549

  Lomazzi, Marta ^a   Slesinger, Paul A ^b   Lüscher, Christian ^a,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; AMPHETAMINE; COCAINE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL 3; METHAMPHETAMINE; MORPHINE; RGS PROTEIN; RGS2 PROTEIN; UNCLASSIFIED DRUG;

ADDICTION; ARTICLE; CHANNEL GATING; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REWARD; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM;

ANIMALS; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GTP-BINDING PROTEIN REGULATORS; HUMANS; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS;

EID: 54349084247     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2008.07.011     Document Type: Article

References (48)

1. B receptor agonists on the mesolimbic dopamine system. Nat. Neurosci. 7 (2004) 153-159
2. B receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nat. Neurosci. 10 (2007) 1559-1568
3. + channels: Kir2.0 and Kir3.0. Rev. Physiol. Biochem. Pharmacol. 145 (2002) 47-179
4. + channel, GIRK. Neuron 33 (2002) 87-99
5. Clancy S.M., et al. Pertussis-toxin-sensitive Gα subunits selectively bind to C-terminal domain of neuronal GIRK channels: evidence for a heterotrimeric G-protein-channel complex. Mol. Cell. Neurosci. 28 (2005) 375-389
6. Hanyaloglu A.C., and von Zastrow M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 537-568
7. Kelly E., et al. Agonist-selective mechanisms of GPCR desensitization. Br. J. Pharmacol. 153 Suppl. 1 (2008) S379-S388
8. Altier C., et al. ORL1 receptor-mediated internalization of N-type calcium channels. Nat. Neurosci. 9 (2006) 31-40
9. Willard F.S., et al. Return of the GDI: the GoLoco motif in cell division. Annu. Rev. Biochem. 73 (2004) 925-951
10. Ross E.M., and Wilkie T.M. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69 (2000) 795-827
11. Pierce K.L., et al. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3 (2002) 639-650
12. Willars G.B. Mammalian RGS proteins: multifunctional regulators of cellular signalling. Semin. Cell Dev. Biol. 17 (2006) 363-376
13. Traynor J.R., and Neubig R.R. Regulator of G protein signaling and drugs of abuse. Mol. Interv. 5 (2005) 30-41
14. Dohlman H.G., et al. Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpa1 (the G-protein α subunit). Mol. Cell. Biol. 16 (1996) 5194-5209
15. Koelle M.R., and Horvitz H.R. EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84 (1996) 115-125
16. Hollinger S., and Hepler J.R. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54 (2002) 527-559
17. Bouhamdan M., et al. Brain-specific regulator of G-protein signaling 9-2 selectively interacts with α-actinin-2 to regulate calcium-dependent inactivation of NMDA receptors. J. Neurosci. 26 (2006) 2522-2530
18. Xie G.X., and Palmer P.P. How regulators of G protein signaling achieve selective regulation. J. Mol. Biol. 366 (2007) 349-365
19. + channels. Eur. J. Biochem. 267 (2000) 5830-5836
20. + channels. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10461-10466
21. Herlitze S., et al. New roles for RGS2. 5 and 8 on the ratio-dependent modulation of recombinant GIRK channels expressed in Xenopus oocytes. J. Physiol. 517 (1999) 341-352
22. + channels. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11727-11732
23. q and m1 muscarinic cholinergic receptor. Steady-state balance of receptor-mediated activation and GTPase-activating protein-promoted deactivation. J. Biol. Chem. 271 (1996) 7999-8007
24. Benians A., et al. Regulators of G-protein signaling form a quaternary complex with the agonist, receptor, and G-protein. A novel explanation for the acceleration of signaling activation kinetics. J. Biol. Chem. 280 (2005) 13383-13394
25. + currents. J. Biol. Chem. 274 (1999) 9899-9904
26. Doupnik C.A. GPCR-Kir channel signaling complexes: defining rules of engagement. J. Recept. Signal Transduct. Res. 28 (2008) 83-91
27. Jaen C., and Doupnik C.A. RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling. J. Biol. Chem. 281 (2006) 34549-34560
28. B receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins. J. Physiol. 580 (2007) 51-65
29. Doupnik C.A., et al. Measuring the modulatory effects of RGS proteins on GIRK channels. Methods Enzymol. 389 (2004) 131-154
30. + (GIRK) channels composed of GIRK2 and GIRK3. J. Biol. Chem. 275 (2000) 36211-36216
31. Jaen C., and Doupnik C.A. Neuronal Kir3.1/Kir3.2a channels coupled to serotonin 1A and muscarinic m2 receptors are differentially modulated by the 'short' RGS3 isoform. Neuropharmacology 49 (2005) 465-476
32. Lüscher C., and Ungless M.A. The mechanistic classification of addictive drugs. PLoS Med. 3 (2006) e437
33. Rahman Z., et al. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38 (2003) 941-952
34. Pepperl D.J., et al. Regulation of RGS mRNAs by cAMP in PC12 cells. Biochem. Biophys. Res. Commun. 243 (1998) 52-55
35. Carlezon W.A.J., et al. The many faces of CREB. Trends Neurosci. 28 (2005) 436-445
36. Zhong H., and Neubig R.R. Regulator of G protein signaling proteins: novel multifunctional drug targets. J. Pharmacol. Exp. Ther. 297 (2001) 837-845
37. Zachariou V., et al. Essential role for RGS9 in opiate action. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13656-13661
38. Lopez-Fando A., et al. Expression of neural RGS-R7 and Gβ5 Proteins in response to acute and chronic morphine. Neuropsychopharmacology 30 (2005) 99-110
39. Bishop G.B., et al. Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol. Dis. 10 (2002) 334-343
40. Gold S.J., et al. Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur. J. Neurosci. 17 (2003) 971-980
41. Ingi T., et al. Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J. Neurosci. 18 (1998) 7178-7188
42. Zhang D., et al. Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology 30 (2005) 1443-1454
43. Burchett S.A., et al. RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. J. Neurochem. 72 (1999) 1529-1533
44. 2 dopamine receptors. J. Neurochem. 96 (2006) 1606-1615
45. Schultz W. Behavioral theories and the neurophysiology of reward. Annu. Rev. Psychol. 57 (2006) 87-115
46. Redish A.D. Addiction as a computational process gone awry. Science 306 (2004) 1944-1947
47. 2 receptors: clues for RGS2 and RGS4 functions. J. Neurochem. 84 (2003) 1118-1127
48. Thirunavukkarasu K., et al. Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells. J. Cell. Biochem. 85 (2002) 837-850